PRESS AND MEDIA

Register here to receive our news releases.

MEDIA SUPPORT

To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:

Kathy Robertson
Principal manager
Media relations and corporate communication

Email: Kathy Robertson

Tel: (351) 211 21 02 00/32

Mobile. (351) 935 994 027

News

Displaying 1 - 20 of 24

photo of the EMCDDA premises

Board re-elects French member Laura d’Arrigo as Chair and Austrian member Franz Pietsch as Vice-Chair

The EMCDDA Management Board, meeting in Lisbon this week, held elections today for the positions of Chair and Vice-Chair of the Board. Laura d’Arrigo (France), Diplomatic advisor at the French Interministerial Mission...

EMCDDA takes stock of EU-ANSA activities in 2018

This month, the EMCDDA approaches the end of its presidency of the EU Agencies’ Network on Scientific Advice (EU-ANSA) and looks back on a productive year (1). EU-ANSA is one of the...

Signature of working arrangements with five EU agencies

Europe’s ability to rapidly respond to public health and social threats caused by new psychoactive substances (NPS/‘new drugs’) has been significantly strengthened thanks to new legislation applying from 23 November (1). The...

paper chain

2018 Reitox week focuses on ‘futures’

Representatives of candidate, potential candidate and neighbouring countries of the EU and countries of Central Asia are joining members of the EMCDDA’s Reitox network (1) in Lisbon from 12–16 November for the...

Lisbon to host Third European conference on addictive behaviours and dependencies — Registration and call for abstracts now open

Leading international experts in the field of addiction science will meet in Lisbon from 23–25 October 2019 for the Third European conference on addictive behaviours and dependencies. The theme of the conference...

Alexis Goosdeel pays official visit to Cyprus

EMCDDA Director Alexis Goosdeel is paying an official visit to Cyprus today, where he is meeting with health and security officials. This is in line with the EMCDDA Strategy 2025, which aims...

Man and woman shaking hands (close-up)

EMCDDA and the Republic of Albania strengthen their cooperation

EMCDDA Director Alexis Goosdeel is participating this week in the EU-Western Balkans Ministerial Forum on Justice and Home Affairs, taking place from 4–5 October in Tirana. Organised under the auspices of the...

Berlin at night

EMCDDA Director meets German Drug Commissioner

EMCDDA Director Alexis Goosdeel is paying an official visit to Germany today at the invitation of the Federal Drug Commissioner Marlene Mortler. Discussions will centre on the further development of cooperation between...

EMCDDA at 3rd Inter-sessional meeting of the UN Commission on Narcotic Drugs

Today, EMCDDA Director Alexis Goosdeel is addressing the 3rd Inter-sessional meeting of the United Nations Commission on Narcotic Drugs (CND) in Vienna. The four-day meeting will focus on: demand reduction; access to...

EMCDDA Director meets President of the European Forum for Urban Security

Director Alexis Goosdeel was in Belgium today where he met with Willy Demeyer, Mayor of Liège and currently President of the European Forum for Urban Security (EFUS). The purpose of the meeting...

Alexis Goosdeel meets new Executive Director of Europol

Alexis Goosdeel meets new Executive Director of Europol

EMCDDA Director Alexis Goosdeel today visited his new counterpart at Europol, Ms Catherine De Bolle in the first official meeting between the two heads of agencies. In a wide-ranging meeting, the two...

Seventh European drugs summer school kicks off in Lisbon with record number of students

The seventh European drugs summer school (EDSS) — ‘Illicit drugs in Europe: demand, supply and public policies’ — opens today in Lisbon on the eve of International day against drug abuse and...

photo report cover

EMCDDA: resurgence of cocaine in a dynamic drug market

Evidence of increased cocaine availability is highlighted by the EMCDDA today in its European Drug Report 2018: Trends and Developments released in Brussels. The development occurs in the context of a dynamic...

EMCDDA Director visits IN-Mouraria harm-reduction centre

This week, EMCDDA Director Alexis Goosdeel and members of his staff have been visiting IN-Mouraria, a low-threshold harm-reduction centre based in Lisbon. In 2019, the centre will become a managing partner of...

EMCDDA Director addresses Lithuanian drug policy conference

EMCDDA Director Alexis Goosdeel will address a conference hosted by the Lithuanian Drug, Tobacco and Alcohol Control Department (NTAKD) in Vilnius today, as the organisation prepares to present a new strategy (2018–2028)...

Coming soon: European Drug Report 2018

The European Drug Report 2018: Trends and Developments will be launched on 7 June in Brussels. Accompanying the report will be the 2018 Statistical Bulletin, and 30 Country Drug Reports, presenting summaries...

Promoting evidence-based health decision-making

Facilitating evidence-based health decision-making among professionals, patients and policymakers will be just one of the issues discussed today by EMCDDA Director Alexis Goosdeel and Chief Executive Officer of the Cochrane Collaboration Mark...

Council adopts conclusions on alternatives to coercive sanctions for drug using offenders

The Justice and Home Affairs Council has adopted today Council conclusions on alternatives to coercive sanctions for drug using offenders.

EMCDDA publications stand

61st Commission on Narcotic Drugs, 12-18 March 2018, Vienna

The United Nations Commission on Narcotic Drugs (CND), the central UN policy-making body on drug-related matters, holds its 61st session in Vienna from 12–18 March 2018. The CND meets every year to...

CADAP delegates

EMCDDA continues support for EU drug-related regional programme in Central Asia

The Central Asian Drug Action Programme (CADAP), is currently in its sixth phase and reflects the EU’s long-term engagement with Central Asian partners to help further strengthen their national policies in drug...